Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. (17th February 2015)

• Record Type: Journal Article
• Authors: Chartier, Karen G.; Sanchez, Katherine; Killeen, Therese K.; Burrow, Allison; Carmody, Thomas; Greer, Tracy L.; Trivedi, Madhukar H.
• Is Part Of: American journal on addictions. Volume 24:Number 4(2015)
• Page Start: 336
• Page End: 340
• Publication Date: 2015-02-17
• Subjects: Substance abuse -- Periodicals; Substance abuse -- Treatment -- Periodicals; 616.86005
• DOI: 10.1111/ajad.12190
• Languages: English
• ISSNs: 1055-0496

Abstract

<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ajad12190-sec-0001" sec-type="section"> <title>Background and Objectives</title> <p>Gender‐specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample (<italic>N</italic> = 302).</p> </sec> <sec id="ajad12190-sec-0002" sec-type="section"> <title>Method</title> <p>Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant‐reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity.</p> </sec> <sec id="ajad12190-sec-0003" sec-type="section"> <title>Results</title> <p>Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety‐related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity.</p> </sec> <sec id="ajad12190-sec-0004" sec-type="section"> <title>Discussion and Conclusions</title> <p>Women were more sensitive to anxiety‐related stimulant withdrawal symptoms.</p> </sec> <sec id="ajad12190-sec-0005" sec-type="section"> <title>Scientific Significance</title> <p>Clinics that address anxiety‐related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. (Am J Addict 2015;XX:XX –XX)</p> </sec> </abstract>